EVERY YEAR, IT BECOMES TOUGHER FOR CLINICAL LABORATORIES WITH NEW GENETIC AND OTHER TESTS to obtain favorable coverage decisions by government and private payers. Not only does it take longer to get a decision from a payer, but payers today want to see more complete data on the analytical and clinical validity of the test …
Getting Payer Coverage for New Tests Continues to Be Difficult Read More »
To access this post, you must purchase The Dark Report.